drugset / Trial / NCT02123849

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

NCT02123849

Phase 2 Completed 54 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized phase II trial studies the safety and effects of acetylsalicylic acid (aspirin) taken continuously or intermittently on gene expression in the nasal tissue of current smokers. Smokers are at increased risk of developing lung cancer. Acetylsalicylic acid may be useful in preventing lung cancer.

Timeline

Start
2014-06
Primary completion
2016-09
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule Oral